Eduardo Ramacciotti

3.2k total citations
82 papers, 1.4k citations indexed

About

Eduardo Ramacciotti is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Eduardo Ramacciotti has authored 82 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Internal Medicine, 36 papers in Cardiology and Cardiovascular Medicine and 31 papers in Surgery. Recurrent topics in Eduardo Ramacciotti's work include Venous Thromboembolism Diagnosis and Management (54 papers), Atrial Fibrillation Management and Outcomes (30 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (11 papers). Eduardo Ramacciotti is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (54 papers), Atrial Fibrillation Management and Outcomes (30 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (11 papers). Eduardo Ramacciotti collaborates with scholars based in United States, Brazil and Canada. Eduardo Ramacciotti's co-authors include Thomas W. Wakefield, Peter K. Henke, Daniel D. Myers, Angela E. Hawley, Shirley K. Wrobleski, Jawed Fareed, Jeffrey I. Weitz, David García, Diana Farris and Anthony J. Comerota and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Eduardo Ramacciotti

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eduardo Ramacciotti United States	24	693	549	345	321	185	82	1.4k
Fionnuala Ní Áinle Ireland	22	673 1.0×	453 0.8×	216 0.6×	698 2.2×	210 1.1×	120	1.8k
Prakash Vishnu United States	20	382 0.6×	302 0.6×	199 0.6×	297 0.9×	247 1.3×	67	1.4k
Brian R. Branchford United States	21	765 1.1×	284 0.5×	246 0.7×	899 2.8×	112 0.6×	69	1.5k
Aldo Salvi Italy	17	412 0.6×	322 0.6×	116 0.3×	342 1.1×	232 1.3×	49	1.4k
Bryce A. Kerlin United States	22	415 0.6×	252 0.5×	216 0.6×	904 2.8×	341 1.8×	86	1.9k
Fabrizio Fabris Italy	25	349 0.5×	187 0.3×	542 1.6×	1.1k 3.3×	333 1.8×	102	2.0k
H. Heinrichs Germany	12	375 0.5×	349 0.6×	313 0.9×	479 1.5×	284 1.5×	29	2.0k
Nelly G. Adel United States	9	223 0.3×	193 0.4×	155 0.4×	108 0.3×	159 0.9×	27	1.4k
Ulrike M. Reiss United States	19	192 0.3×	93 0.2×	212 0.6×	552 1.7×	453 2.4×	56	1.7k
Simone Saibeni Italy	28	198 0.3×	65 0.1×	850 2.5×	313 1.0×	136 0.7×	99	2.3k

Countries citing papers authored by Eduardo Ramacciotti

Since Specialization

Citations

This map shows the geographic impact of Eduardo Ramacciotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Ramacciotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Ramacciotti more than expected).

Fields of papers citing papers by Eduardo Ramacciotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Ramacciotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Ramacciotti. The network helps show where Eduardo Ramacciotti may publish in the future.

Co-authorship network of co-authors of Eduardo Ramacciotti

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Ramacciotti. A scholar is included among the top collaborators of Eduardo Ramacciotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Ramacciotti. Eduardo Ramacciotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Caffaro, Roberto Augusto, et al.. (2025). Topical oxybutynin deodorant for axillary hyperhidrosis: a topic or a systemic effect? Rationale and design of the phase II today trial. Jornal Vascular Brasileiro. 24. e20240098–e20240098.

Ramacciotti, Eduardo, et al.. (2024). Venous thromboembolism risk models in hospitalized medical patients: the time for implementation, not never-ending development. Research and Practice in Thrombosis and Haemostasis. 8(4). 102473–102473.

Siddiqui, Fakiha, Debra Hoppensteadt, Walter Jeske, et al.. (2024). Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate. Clinical and Applied Thrombosis/Hemostasis. 30. 3005429062–3005429062. 2 indexed citations

Kipshidze, N., et al.. (2024). AtheroVax: a peptide vaccine with a therapeutic effect in animal model of chronic inflammation. European Heart Journal. 45(Supplement_1).

Ramacciotti, Eduardo, Leandro Barile Agati, Fernando Crivelenti Vilar, et al.. (2023). Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da Sociedade Brasileira de Medicina Tropical. 56. e0565–e0565. 7 indexed citations

Iversen, Patrick L., Nicholas Kipshidze, Nodar Kipshidze, et al.. (2023). A novel therapeutic vaccine targeting the soluble TNFα receptor II to limit the progression of cardiovascular disease: AtheroVax™. Frontiers in Cardiovascular Medicine. 10. 1206541–1206541. 5 indexed citations

Schulman, Sam, Michelle Sholzberg, Alex C. Spyropoulos, et al.. (2022). ISTH guidelines for antithrombotic treatment in COVID‐19. Journal of Thrombosis and Haemostasis. 20(10). 2214–2225. 91 indexed citations

Caffaro, Roberto Augusto, et al.. (2022). The impact of dermatoscopy on the pretreatment assessment of lower limbs telangiectasias: a prospective study. International Angiology. 41(5). 413–419. 1 indexed citations

Iqbal, Omer, Jeanine M. Walenga, Bruce Lewis, et al.. (2021). An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clinical and Applied Thrombosis/Hemostasis. 27. 2975203002–2975203002. 33 indexed citations

10.

Orsi, Fernanda Andrade, Erich Vinícius De Paula, Ariane Vieira Scarlatelli Macedo, et al.. (2020). Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy. Hematology Transfusion and Cell Therapy. 42(4). 300–308. 24 indexed citations

11.

Ramacciotti, Eduardo & Jeffrey I. Weitz. (2019). Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition. Thrombosis Research. 184. 44–49. 4 indexed citations

12.

Ramacciotti, Eduardo, et al.. (2019). Cryo-laser and cryo-sclerotherapy guided by augmented reality for telangiectasias, feeder, and small varicose vein treatment â?? The CLaCS technique white paper report. 12(1). 2 indexed citations

13.

Ramacciotti, Eduardo, et al.. (2018). Medical management of stable peripheral artery disease: the COMPASS trial. Perspectives from a vascular standpoint. International Angiology. 37(4). 255–260. 2 indexed citations

14.

Liu, Xianchen, Lin Xie, Hemant Phatak, et al.. (2013). Abstract 12664: Persistence on Warfarin Therapy in Patients with Venous Thromboembolism: A Large US Insurance Database Analysis. Circulation. 1 indexed citations

15.

García, David, et al.. (2012). Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants. Journal of Thrombosis and Haemostasis. 11(2). 245–252. 85 indexed citations

16.

Moore, Rashida, Angela E. Hawley, Robert E. Sigler, et al.. (2009). Tissue Inhibitor of Metalloproteinase-1 is an Early Marker of Acute Endothelial Dysfunction in a Rodent Model of Venous Oxidative Injury. Annals of Vascular Surgery. 23(4). 498–505. 9 indexed citations

17.

Kachman, Maureen, Ann P. Walker, John R. Strahler, et al.. (2008). Microparticle Surface Proteins Are Associated With Experimental Venous Thrombosis: A Preliminary Study. Clinical and Applied Thrombosis/Hemostasis. 15(2). 201–8. 16 indexed citations

18.

Ramacciotti, Eduardo, et al.. (2003). Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis. Thrombosis Research. 109(4). 171–174. 44 indexed citations

19.

Ramacciotti, Eduardo, et al.. (2002). An open-label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.. Blood. 2 indexed citations

20.

Ramacciotti, Eduardo, et al.. (2001). The efficacy and safety of enoxaparin once-daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep-vein thrombosis, a Brazilian multicenter study.. Blood. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact